FDA Inspection
PILPIL – FDA Inspection, Apr 2, 2024
Record Details
This FDA Inspection record concerns PIL, with an inspection on April 2, 2024, issued by the Center for Drug Evaluation and Research, covering drugs.
View Company Profile
ID · eb80af02-f9ce-4a5f-9090-6982bae7faa8
Inspection Facts
Voluntary Action Indicated (VAI)
Objectionable conditions were found, but FDA is not prepared to take or recommend regulatory action.
- Inspection number
- 1235403
- FDA center
- Human Drugs
- Project area
- Bioresearch Monitoring
FDA Citations
1- 21 CFR 312.62(b)Case history records- inadequate or inadequate
Full citation text and observation details available on the Dashboard.
Other FDA inspections of PIL
4| Date | Classification | Office | Project area |
|---|---|---|---|
| September 16, 2025 | NAI | Center for Devices and Radiological Health | Postmarket Assurance: Devices |
| May 3, 2024 | VAI | Center for Devices and Radiological Health | Bioresearch Monitoring |
| January 21, 2022 | NAI | Center for Food Safety and Applied Nutrition | Foodborne Biological Hazards |
| July 30, 2019 | VAI | Center for Food Safety and Applied Nutrition | Foodborne Biological Hazards |
Other documents for PIL
- FDA Inspection 1281758 - 2025-09-16
- FDA Inspection 1237533 - 2024-05-03
- FDA Inspection 1160597 - 2022-01-21
- FDA Inspection 1098214 - 2019-07-30
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.